InvestorsHub Logo

petemantx

07/06/18 3:21 PM

#233672 RE: DaubersUP #233662

Otezla is currently on target to be a $2B/yr drug this year. If Prurisol comes out with 40%PASI75 or better, it should wipe out Otezla and become more of a $6-7B/ yr drug IMO and that may even be conservative.

My valuation is based on Prurisol becoming the first choice for treatment if it exceeds 40%+ as it would then be the safest drug on the market by a wide margin, darn near equal to the biologics for efficacy, and I believe (not positive) that it will also be the most inexpensive treatment.

What doctor wouldn't try Prurisol first and if it doesn't work, then go to the more costly and risky treatments?

BooDog

07/06/18 3:27 PM

#233674 RE: DaubersUP #233662

10 bagger +!! Looking forward to the momentum wiping out resistance.

Volume broke 100K, surprised on a day like today.

Price$0.542 Day's Change


-0.003 (-0.55%) Bid0.541Ask0.547B/A Size1000x2000 Day's High0.57Day's Low0.535 Volume
(Light)




129,855

Monday volume starts picking up imo.

kfcyahoo

07/06/18 8:22 PM

#233729 RE: DaubersUP #233662

DuabersUP,

You state:¨Prurisol phase 2b data is now on the clock. We should see topline in the next 1-4 weeks. That alone may change everything. Imagine a 40-50% PASI 75. Imagine even a 25% pasi 75

I’m leaning towards +40% which IMO would lead to a 2 billion a year drug in the upcoming years¨

I? leaning towards +40%, based upon past company pronoucements(announcements) touted by them(ipix).

Dr. Jeckyl or Mr. Hyde? Wizard of Oz or A Wonderful Life(Jimmy Stewart)?

If either of the former, I´ll be the first one knocking at Michael Sullivan´s Post Office Square door.

Sullivan´s decision to represent ctix( now ipix), is the primary reason I´ve stayed invested.